CD39+γδ Tregs are the predominant Tregs in CRC and mediate direct and robust immunosuppressive effects on CD3+ T cells via the adenosine pathway — but independently of TGF-β or IL-10 (14). The gene discussed is ENTPD1; the disease is colorectal carcinoma.